{"product_id":"global-and-japan-human-organs-on-chip-market-report-forecast-2023-2029","title":"Global and Japan Human Organs-on-Chip Market Report \u0026 Forecast 2023-2029","description":"\u003cp\u003eGlobal and Japan Human Organs-on-Chip Market Report \u0026amp; Forecast 2023-2029\u003c\/p\u003e\n\n\u003cp\u003eMarket Analysis and Insights: Global and Japan Human Organs-on-Chip Market\u003c\/p\u003e\n\n\u003cp\u003eThis report focuses on global and Japan Human Organs-on-Chip market, also covers the segmentation data of other regions in regional level and county level.\u003c\/p\u003e\n\n\u003cp\u003eThe global Human Organs-on-Chip revenue was at US$ 87.87 million in the year 2022, is projected to reach a revised size of US$ 621.29 million by 2029, growing at a CAGR of 31.21% during the forecast period 2023-2029.\u003c\/p\u003e\n\n\u003cp\u003eIn Japan the Human Organs-on-Chip revenue is expected to grow from US$ 6.63 million in 2022 to US$ 58.68 million by 2029, at a CAGR of 34.78% during the forecast period (2023-2029).\u003c\/p\u003e\n\n\u003cp\u003eThe global key players of Human Organs-on-Chip include Emulate, Mimetas, TissUse, Valo Health, CN Bio Innovations, Hesperos, Draper Laboratory, Nortis, and Micronit Microtechnologies B.V., etc. The global five biggest players hold a share of 58.32% in 2022.\u003c\/p\u003e\n\n\u003cp\u003eGlobal Human Organs-on-Chip Scope and Market Size\u003c\/p\u003e\n\n\u003cp\u003eHuman Organs-on-Chip market is segmented in regional and country level, by players, by Type, and by End User. Players, stakeholders, and other participants in the global Human Organs-on-Chip market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by End User for the period 2018-2029.\u003c\/p\u003e\n\n\u003cp\u003eFor Japan market, this report focuses on the Human Organs-on-Chip market size by players, by Type, and by End User, for the period 2018-2029. The key players include the global and local players which play important roles in Japan.\u003c\/p\u003e\n\n\u003cp\u003eBy Company\u003c\/p\u003e\n\n\u003cp\u003eEmulate\u003c\/p\u003e\n\n\u003cp\u003eMimetas\u003c\/p\u003e\n\n\u003cp\u003eTissUse\u003c\/p\u003e\n\n\u003cp\u003eValo Health\u003c\/p\u003e\n\n\u003cp\u003eCN Bio Innovations\u003c\/p\u003e\n\n\u003cp\u003eHesperos\u003c\/p\u003e\n\n\u003cp\u003eDraper Laboratory\u003c\/p\u003e\n\n\u003cp\u003eNortis\u003c\/p\u003e\n\n\u003cp\u003eMicronit Microtechnologies B.V.\u003c\/p\u003e\n\n\u003cp\u003eKirkstall\u003c\/p\u003e\n\n\u003cp\u003eCherry Biotech SAS\u003c\/p\u003e\n\n\u003cp\u003eElse Kooi Laboratory\u003c\/p\u003e\n\n\u003cp\u003eAltis Biosystems\u003c\/p\u003e\n\n\u003cp\u003eBi\/ond\u003c\/p\u003e\n\n\u003cp\u003eNetri\u003c\/p\u003e\n\n\u003cp\u003eXona Microfluidics\u003c\/p\u003e\n\n\u003cp\u003eSynVivo\u003c\/p\u003e\n\n\u003cp\u003eBeijing Daxiang Biotech\u003c\/p\u003e\n\n\u003cp\u003eSegment by Type\u003c\/p\u003e\n\n\u003cp\u003eBrain-on-a-chip\u003c\/p\u003e\n\n\u003cp\u003eLiver-on-a-chip\u003c\/p\u003e\n\n\u003cp\u003eKidney-on-a-chip\u003c\/p\u003e\n\n\u003cp\u003eLung-on-a-chip\u003c\/p\u003e\n\n\u003cp\u003eHeart-on-a-chip\u003c\/p\u003e\n\n\u003cp\u003eIntestine-on-a-chip\u003c\/p\u003e\n\n\u003cp\u003eVessel-on-a-chip\u003c\/p\u003e\n\n\u003cp\u003eOther Organs\u003c\/p\u003e\n\n\u003cp\u003eSegment by End User\u003c\/p\u003e\n\n\u003cp\u003ePharmaceutical \u0026amp; Biotechnology Companies\u003c\/p\u003e\n\n\u003cp\u003eAcademic \u0026amp; Research Institutes\u003c\/p\u003e\n\n\u003cp\u003eCosmetics Industry\u003c\/p\u003e\n\n\u003cp\u003eOthers\u003c\/p\u003e\n\n\u003cp\u003eBy Region\u003c\/p\u003e\n\n\u003cp\u003eAmericas\u003c\/p\u003e\n\n\u003cp\u003eUnited States\u003c\/p\u003e\n\n\u003cp\u003eCanada\u003c\/p\u003e\n\n\u003cp\u003eMexico\u003c\/p\u003e\n\n\u003cp\u003eBrazil\u003c\/p\u003e\n\n\u003cp\u003eChina\u003c\/p\u003e\n\n\u003cp\u003eAPAC (excluding China)\u003c\/p\u003e\n\n\u003cp\u003eJapan\u003c\/p\u003e\n\n\u003cp\u003eSouth Korea\u003c\/p\u003e\n\n\u003cp\u003eChina Taiwan\u003c\/p\u003e\n\n\u003cp\u003eASEAN\u003c\/p\u003e\n\n\u003cp\u003eIndia\u003c\/p\u003e\n\n\u003cp\u003eEMEA\u003c\/p\u003e\n\n\u003cp\u003eEurope\u003c\/p\u003e\n\n\u003cp\u003eMiddle East\u003c\/p\u003e\n\n\u003cp\u003eAfrica\u003c\/p\u003e\n\n\u003cp\u003eChapter Introduction\u003c\/p\u003e\n\n\u003cp\u003eChapter 1: Introduces Human Organs-on-Chip definition, global market size, Japan market size, Japan percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.\u003c\/p\u003e\n\n\u003cp\u003eChapter 2: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.\u003c\/p\u003e\n\n\u003cp\u003eChapter 3: Provides the analysis of various market segments by End User, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.\u003c\/p\u003e\n\n\u003cp\u003eChapter 4: Detailed analysis of Human Organs-on-Chip companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.\u003c\/p\u003e\n\n\u003cp\u003eChapter 5: Revenue of Human Organs-on-Chip in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.\u003c\/p\u003e\n\n\u003cp\u003eChapter 6: Americas by Type, by End User and by country, revenue for each segment.\u003c\/p\u003e\n\n\u003cp\u003eChapter 7: EMEA by Type, by End User and by region, revenue for each segment.\u003c\/p\u003e\n\n\u003cp\u003eChapter 8: China by Type, and by End User, revenue for each segment.\u003c\/p\u003e\n\n\u003cp\u003eChapter 9: APAC (excluding China) by Type, by End User and by region, revenue for each segment.\u003c\/p\u003e\n\n\u003cp\u003eChapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Organs-on-Chiprevenue, gross margin, and recent development, etc.\u003c\/p\u003e\n\n\u003cp\u003eChapter 11: Analyst's Viewpoints\/Conclusions\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"April, 2023 \/ 159 Pages \/ MCW16229110","offer_id":47646915559730,"sku":null,"price":5220.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-and-japan-human-organs-on-chip-market-report-forecast-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}